对阿尔茨海默病的查:数量中的力量
Augustin Moreau1, Nathalie Philippi1
1Geriatrics and Neurology Departments, Research and Resources Memory Center (CM2R), Strasbourg University Hospitals, Strasbourg, France.
Journal of Alzheimer's disease : JAD
|December 29, 2025
概括
结合迷你心理状态检查 (MMSE) 和蒙特利尔认知评估 (MoCA),可以有效预测痴呆风险. 在这两项测试中得分低于正常的患者面临着明显更高的痴呆风险.
科学领域:
- 神经学 神经学
- 老年学是一门学科.
- 临床神经心理学 临床神经心理学
背景情况:
- 包括痴呆症在内的神经认知障碍在临床实践中构成了重大挑战.
- 早期发现痴呆症对于及时干预和管理至关重要.
- 识别高血管风险的个体需要有效的查工具.
研究的目的:
- 评估小型精神状态检查 (MMSE) 和蒙特利尔认知评估 (MoCA) 在预测痴呆转换方面的联合实用性.
- 评估与高血管风险患者的MMSE和MoCA病理评分相关的痴呆风险.
主要方法:
- 对高血管风险患者的回顾性分析.
- 使用了迷你心理状态考试 (MMSE) 和蒙特利尔认知评估 (MoCA) 的分数.
- 在随访期间,与随后的痴呆症诊断相关的测试结果.
主要成果:
- 患有MMSE和MoCA病理评分的患者表现出患痴呆症转换的风险大幅增加.
- 一个单一的病理评分表明,与两项测试的正常分数相比,痴呆症风险较低,但仍然增加.
结论:
- 结合MMSE和MoCA,比单独使用这两种测试更能对痴呆风险进行更可靠的预测.
- 使用综合认知评估进行早期查对于识别有风险的个体至关重要.
- 这种方法有助于更好地选择患者接受专门的痴呆症护理和研究.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
33.7K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.5K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
